Medicinal plants have been studied for potential endophytic interactions and numerous studies have provided evidence that seeds harbor diverse microbial communities, not only on their surfaces but also within the embryo. Adenosine deaminase (ADA) is known as a potential therapeutic target for the treatment of lymphoproliferative disorders and cancer. Therefore, in this study, 20 types of medicinal plant seeds were used to screen endophytic fungi with tissue homogenate and streak. In addition, 128 morphologically distinct endophyte strains were isolated and their ADA inhibitory activity determined by a spectrophotometric assay. The strain with the highest inhibitory activity was identified as Cochliobolus sp. Seven compounds were isolated from the strain using a chromatography method. Compound 3 showed the highest ADA inhibitory activity and was identified as 5-hydroxy-2-hydroxymethyl-4H-pyran-4-one, based on the results of 1H and 13C NMR spectroscopy. The results of molecular docking suggested that compound 3 binds to the active site and the nonspecific binding site of the ADA. Furthermore, we found that compound 3 is a mixed ADA inhibitor. These results indicate that endophytic strains are a promising source of ADA inhibitors and that compound 3 may be a superior source for use in the preparation of biologically active ADA inhibitor compounds used to treat cancer.

School of Life Science and Engineering Key Laboratory of Herbal Tebitan Drug Screening and Deep Processing of Gansu Province Lanzhou University of Technology Lanzhou 730050 China

See more in PubMed

Anal Biochem. 1983 Feb 15;129(1):207-9 PubMed

Bioorg Chem. 2018 Feb;76:249-257 PubMed

Molecules. 2018 Jan 05;23(1): PubMed

Pharmacol Ther. 1982;17(3):399-429 PubMed

Mol Biol Evol. 2013 Dec;30(12):2725-9 PubMed

Ceska Slov Farm. 2000 Nov;49(6):288-98 PubMed

Clin Infect Dis. 2007 Apr 15;44(8):1108-14 PubMed

Cancer Chemother Pharmacol. 1980;4(4):227-35 PubMed

Folia Microbiol (Praha). 2002;47(1):32-6 PubMed

J Mol Graph Model. 1999 Feb;17(1):57-61 PubMed

Arch Med Sci. 2013 Aug 30;9(4):601-7 PubMed

Med Res Rev. 2001 Mar;21(2):105-28 PubMed

Int J Biol Macromol. 2018 May;111:237-246 PubMed

Biochem J. 1969 Nov;115(3):15P PubMed

Acta Crystallogr D Biol Crystallogr. 1999 Dec;55(Pt 12):2031-2 PubMed

Biochim Biophys Acta. 2001 Mar 9;1546(1):185-95 PubMed

PLoS One. 2012;7(11):e47865 PubMed

J Comput Chem. 2009 Dec;30(16):2785-91 PubMed

Int J Biochem Cell Biol. 1995 Jul;27(7):701-6 PubMed

Environ Microbiol. 2011 Sep;13(9):2508-17 PubMed

Biochimie. 2004 Apr-May;86(4-5):311-5 PubMed

Curr Microbiol. 2018 May;75(5):565-573 PubMed

Braz J Microbiol. 2015 Mar 31;46(1):49-57 PubMed

J Antibiot (Tokyo). 1995 Aug;48(8):773-9 PubMed

Appl Biochem Biotechnol. 2015 Nov;177(6):1241-51 PubMed

Folia Microbiol (Praha). 1996;41(6):473-6 PubMed

J Comput Chem. 2010 Jan 30;31(2):455-61 PubMed

Cent Eur J Public Health. 2004 Mar;12 Suppl:S16-8 PubMed

J Org Chem. 2011 Apr 15;76(8):2899-903 PubMed

Annu Rev Phytopathol. 2004;42:271-309 PubMed

J Appl Toxicol. 2008 May;28(4):554-9 PubMed

Chem Pharm Bull (Tokyo). 1997 Dec;45(12):1955-60 PubMed

Chem Biodivers. 2012 Feb;9(2):418-27 PubMed

Chin J Nat Med. 2015 Dec;13(12):942-53 PubMed

N Engl J Med. 1983 Dec 15;309(24):1486-90 PubMed

Food Chem Toxicol. 2004 Jan;42(1):93-105 PubMed